Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis.
Polymorphisms in DNA double-strand break repair gene XRCC2 may play an important role in colorectal cancer etiology, specifically in disease subtypes. Associations of XRCC2 variants and colorectal cancer were investigated by tumor site and tumor instability status in a four-center collaboration including three U.K. case-control studies (Sheffield, Leeds, and Dundee) and a U.S. case-control study of cases from high-risk Utah pedigrees (total: 1,252 cases and 1,422 controls). The 14 variants studied were tagging single nucleotide polymorphisms (SNP) selected from National Institute of Environmental Health Sciences/HapMap data supplemented with SNPs identified from sequencing of 125 cases chosen to represent multiple colorectal cancer groups (familial, metastatic disease, and tumor subsite). Monte Carlo significance testing using Genie software provided valid meta-analyses of the total resource that includes family-based data. Similar to reports of colorectal cancer and other cancer sites, the rs3218536 R188H allele was not associated with increased risk. However, we observed a novel, highly significant association of a common SNP, rs3218499G>C, with increased risk of rectal tumors (odds ratio, 2.1; 95% confidence interval, 1.3-3.3; P(chi2) = 0.0006) versus controls, with the largest risk found for female rectal cases (odds ratio, 3.1; 95% confidence interval, 1.6-6.1; P(chi2) = 0.0006). This difference was significantly different to that for proximal and distal colon cancers (P(chi2) = 0.02). Our investigation supports a role for XRCC2 in colorectal cancer tumorigenesis, conferring susceptibility to rectal tumors.
Curtin
Karen
K
Genetic Epidemiology, University of Utah School of Medicine, 391 Chipeta Way Suite D2, Salt Lake City, UT 84108, USA. karen.curtin@hsc.utah.edu
Lin
Wei-Yu
WY
George
Rina
R
Katory
Mark
M
Shorto
Jennifer
J
Cannon-Albright
Lisa A
LA
Smith
Gillian
G
Bishop
D Timothy
DT
Cox
Angela
A
Camp
Nicola J
NJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
D004268:DNA-Binding Proteins; C113187:XRCC2 protein, human
Am J Surg Pathol. 2008 Aug;32(8):1246-51
18677806
Hum Mol Genet. 2002 Jun 1;11(12):1399-407
12023982
Int J Cancer. 2008 Nov 15;123(10):2456-9
18712731
Cell. 1997 Jan 24;88(2):265-75
9008167
Carcinogenesis. 2002 Nov;23(11):1839-49
12419832
Genet Epidemiol. 2004 Jan;26(1):11-21
14691953
Br J Cancer. 2009 Jan 27;100(2):412-20
19127255
J Br Menopause Soc. 2005 Dec;11(4):166-72
16354462
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):1016-9
18398049
Dis Colon Rectum. 2009 Jul;52(7):1304-11
19571709
Nature. 1999 Sep 23;401(6751):397-9
10517641
J Mol Diagn. 2008 Jul;10(4):293-300
18556767
Hum Mol Genet. 2006 Nov 1;15(21):3263-71
17000706
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8
16609022
EMBO J. 2006 Jan 11;25(1):222-31
16395335
Nature. 2001 Apr 12;410(6830):766-7
11298430
Carcinogenesis. 2003 Feb;24(2):249-53
12584174
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3482-9
19064565
Am J Pathol. 2001 Apr;158(4):1517-24
11290569
Breast Cancer Res Treat. 2008 Dec;112(3):575-9
18188695
BMC Bioinformatics. 2007 Nov 15;8:448
18005446
J Natl Cancer Inst. 2009 Jan 7;101(1):24-36
19116388
BMC Proc. 2007;1 Suppl 1:S12
18466461
Hum Genet. 2006 May;119(4):376-88
16485136
IARC Sci Publ. 2002;(155):1-781
12812229
Carcinogenesis. 2004 Feb;25(2):189-95
14578164
Nature. 2003 Jan 30;421(6922):499-506
12556884
Int J Cancer. 2004 Nov 1;112(2):259-64
15352038
Genes Dev. 1999 Oct 15;13(20):2633-8
10541549
Br J Cancer. 2001 Mar 2;84(5):722-7
11237397
Oncogene. 2007 Dec 10;26(56):7799-808
18066093
Nat Cell Biol. 2000 Oct;2(10):757-61
11025669
Curr Opin Genet Dev. 2000 Apr;10(2):144-50
10753787
BMC Bioinformatics. 2006 Apr 18;7:209
16620382
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):520-4
15066914
Carcinogenesis. 2003 Feb;24(2):275-82
12584178
Genet Epidemiol. 2003 Nov;25(3):190-202
14557987
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):616-21
19155440
Ann Hum Genet. 2009 Jan;73(1):54-60
19132978
Hum Mol Genet. 2002 Sep 1;11(18):2189-200
12189171
Int J Cancer. 2005 Nov 20;117(4):611-8
15924337
Hum Mol Genet. 2002 Jun 1;11(12):1433-8
12023985
J Natl Cancer Inst. 2006 Oct 4;98(19):1382-96
17018785
Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1090-1
15184273
Am J Gastroenterol. 2008 Feb;103(2):360-7
17986315
Carcinogenesis. 2007 Aug;28(8):1788-93
17557904
Cancer Res. 2001 Jan 1;61(1):126-30
11196149
J Oral Pathol Med. 2008 May;37(5):271-7
18410587
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2557-65
18086758
DNA Repair (Amst). 2009 Jan 1;8(1):60-71
18824251
Cancer Res. 2007 Aug 1;67(15):7534-9
17671225
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):917-23
11535541
Biochem Biophys Res Commun. 2007 Jan 19;352(3):763-8
17141189
Hum Hered. 2002;53(3):146-52
12145550
Dis Colon Rectum. 2003 Aug;46(8):1069-77
12907901
Gut. 2005 May;54(5):636-42
15831908
Int J Cancer. 2004 Dec 10;112(5):901-4
15386379
Bioinformatics. 2008 Sep 15;24(18):2105-7
18653522
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1081-90
15279796